The announcement follows a year of discussions on the partnership, which will aim to improve the spread of evidence-based cancer care in community health centers and facilitate inter-institutional learning.
More specifically, MSK will establish a site for clinical trials at Hartford Hospital, which will make state-of-the-art cancer trials accessible to Hartford-area cancer patients.
MSK will also collaborate with Hartford Hospital on other clinical and research areas through on-site observation, sharing of educational resources, and quality and outcomes research, according to a news release.
Moving forward, the pair plans to put similar systems in place at Hartford HealthCare’s other acute-care hospitals, recruiting a joint physician-in-chief, who will be on staff at MSK and Hartford HealthCare to oversee physician integration between the institutions.
More Articles on Key Specialties:
Spectrum Health Performs Michigan’s First Heart and Lung Transplant in 14 Years
Lawrence + Memorial Cancer Center to Open Doors
Cooley Dickenson Plans to Close Inpatient Pediatrics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
